← All companies

CUVL

Clinuvel Pharmaceuticals Limited

CUVL Nasdaq American Depositary Receipts EDGAR ↗

$5.87

+0.12 +2.09%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$5.60 – $8.92

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Sep 9, 2026

6-K Aug 27, 2026

6-K Aug 20, 2026

6-K Aug 12, 2026

6-K Jul 30, 2026

6-K Jul 28, 2026

6-K Jul 27, 2026

6-K Jul 23, 2026

6-K Jul 22, 2026

6-K Jul 22, 2026

Other filings

SEC STAFF ACTION Jul 17, 2026

424B3 Jul 17, 2026

CERT Jul 17, 2026

CORRESP Jul 15, 2026

CORRESP Jul 9, 2026

CORRESP Jul 6, 2026

CORRESP Jun 15, 2026

20FR12B Jun 15, 2026

UPLOAD Apr 23, 2026

DRSLTR Apr 17, 2026

DRS/A Apr 17, 2026

UPLOAD Apr 7, 2026

DRS/A Mar 30, 2026

DRSLTR Mar 27, 2026

UPLOAD Mar 19, 2026

DRS/A Mar 4, 2026

DRSLTR Mar 4, 2026

UPLOAD Jan 30, 2026

DRS Dec 18, 2025

EFFECT Item F-6; Item 2021-08-16; Item 09:00:00 Aug 16, 2021

F-6 Aug 6, 2021

424B3 Nov 26, 2010

424B3 Mar 20, 2006

SUPPL AUTO-GENERATED PAPER DOCUMENT May 6, 2005

SUPPL AUTO-GENERATED PAPER DOCUMENT Apr 15, 2005

SUPPL AUTO-GENERATED PAPER DOCUMENT Jan 5, 2005

ARS AUTO-GENERATED PAPER DOCUMENT Oct 5, 2004

SUPPL AUTO-GENERATED PAPER DOCUMENT Oct 5, 2004

SUPPL AUTO-GENERATED PAPER DOCUMENT Aug 23, 2004

F-6 FORM F-6 Jun 22, 2004